These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23887450)

  • 41. [Cardiac failure treatment with berlipril: effects on hemodynamics, neurohumoral status and activity of free radical lipid peroxidation].
    Vizir VA; Berzin AE
    Ter Arkh; 1999; 71(8):13-7. PubMed ID: 10515027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats.
    Svalbe B; Zvejniece L; Vavers E; Pugovics O; Muceniece R; Liepinsh E; Dambrova M
    Behav Brain Res; 2011 Sep; 222(1):26-32. PubMed ID: 21420440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinico-immunologic aspects of using mildronate in patients with bronchopulmonary diseases].
    Orlov VA; Sokolova VI; Zamotaev IP; Elagina LV; Zavolovskaia LI
    Antibiot Khimioter; 1990 Jul; 35(7):47-50. PubMed ID: 2149494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of radical scavenging capacity and lipid peroxidation inhibiting capacity of antioxidant.
    Niki E; Omata Y; Fukuhara A; Saito Y; Yoshida Y
    J Agric Food Chem; 2008 Sep; 56(18):8255-60. PubMed ID: 18717567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of tramadol on behavioral alterations and lipid peroxidation after transient forebrain ischemia in rats.
    Nagakannan P; Shivasharan BD; Thippeswamy BS; Veerapur VP
    Toxicol Mech Methods; 2012 Nov; 22(9):674-8. PubMed ID: 22871232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
    Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
    Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of peripheral vestibular disorders using endaural phono-electrophoresis of mildronate].
    Ramazashvili ZI; Kriukov AI; Luchikhin LA
    Vestn Otorinolaringol; 1990; (2):34-9. PubMed ID: 2360306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bi-hemispheric anterior cerebral artery with drop attacks and limb shaking TIAs.
    Gerstner E; Liberato B; Wright CB
    Neurology; 2005 Jul; 65(1):174. PubMed ID: 16009921
    [No Abstract]   [Full Text] [Related]  

  • 49. Transient ischemic attack: definitions and clinical presentations.
    Lewandowski CA; Rao CP; Silver B
    Ann Emerg Med; 2008 Aug; 52(2):S7-16. PubMed ID: 18655918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ischemic stroke and TIA: clinical clues to common causes.
    Poole RM; Chimowitz MI
    Geriatrics; 1994 Jun; 49(6):37-42. PubMed ID: 7911776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LC-MS/MS profiling and neuroprotective effects of Mentat® against transient global ischemia and reperfusion-induced brain injury in rats.
    Viswanatha GL; Kumar LM; Rafiq M; Kavya KJ; Thippeswamy AH; Yuvaraj HC; Azeemuddin M; Anturlikar SD; Patki PS; Babu UV; Ramakrishnan S
    Nutrition; 2015; 31(7-8):1008-17. PubMed ID: 26059376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antiradical and antioxidant activity of derivatives of 1,2,4-triazole and quinazoline in cerebral ischemia].
    Dunaev VV; Belenichev IF; Kovalenko SI; Vashkin IN; Avramenko NA; Mazur IA; Knysh EG; Tishkin VS
    Ukr Biokhim Zh (1978); 1996; 68(1):100-4. PubMed ID: 8755112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.
    Vilskersts R; Liepinsh E; Mateuszuk L; Grinberga S; Kalvinsh I; Chlopicki S; Dambrova M
    Pharmacology; 2009; 83(5):287-93. PubMed ID: 19325254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activity of antioxidant protection enzymes and content of lipid peroxidation products in blood serum and cerebrospinal fluid in patients with ischemic brain disease].
    Dzhandzhgava TG; Shakarishivili RR
    Vopr Med Khim; 1992; 38(2):33-5. PubMed ID: 1413627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are limb-shaking transient ischemic attacks a risk factor for postendarterectomy hemorrhage? Case report and literature review.
    Switzer JA; Nichols FT
    J Neuroimaging; 2008 Jan; 18(1):96-100. PubMed ID: 18190505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cardiotropic characteristics of mildronat].
    Zagorodnyĭ MI; Kazak LI; Svintsitskiĭ AS; Chekman IS
    Lik Sprava; 2005; (3):71-6. PubMed ID: 16025684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain attack. Acute therapeutic interventions. Free radical scavengers and antioxidants.
    Hall ED
    Neurosurg Clin N Am; 1997 Apr; 8(2):195-206. PubMed ID: 9113701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of meldonium in the combination treatment of patients with heart failure in the early postinfarction period].
    Statsenko ME; Shilina NN; Turkina SV
    Ter Arkh; 2014; 86(4):30-5. PubMed ID: 24864465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolated bilateral blindness as the sole manifestation of transient ischaemic attacks.
    Krasnianski M; Bau V; Neudecker S; Lindner A; Zierz S
    Acta Ophthalmol Scand; 2006 Jun; 84(3):415-8. PubMed ID: 16704710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effectiveness of mesoglycan in the prevention of cerebral ischemia].
    Bettini R; Maino C; Gorini M
    Clin Ter; 2003; 154(1):13-6. PubMed ID: 12854278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.